Literature DB >> 1413834

Adrenal cortical carcinoma in Norway, 1970-1984.

J A Søreide1, K Brabrand, S O Thoresen.   

Abstract

Adrenal cortical carcinoma is a rare and highly malignant tumor. This retrospective study includes 99 patients (57 males and 42 females) reported to The Cancer Registry of Norway during the 15 year period from 1970 to 1984. The age adjusted incidence was 1.5 per million per year. Eighty-one patients were diagnosed with adrenal cortical carcinoma when still alive. In 18 cases the diagnosis was first made at autopsy. Median age at diagnosis was 54 years (range 2-88 years) with a slight male predominance. Information about initial symptoms was available in 67 patients, of whom 26 patients (18 females and 8 males) presented with clinically functioning tumors, the Cushing syndrome and virilization being most frequently encountered. Only 28 (35%) of 81 patients diagnosed when still alive had tumors confined to the adrenals. Half of the patients had distant metastases, with lungs and liver being the most frequent sites. Sixty-one patients underwent surgery; 51 patients had a radical or debulking operation and 10 patients had laparotomy with tumor biopsy. After a complete follow-up for at least 6 years (range 6-21 years), only 9 patients were still alive. Early stage (Stage I and II) and curative resection had a significant impact on the outcome of this disease. To improve prognosis, early diagnosis and radical surgery, if feasible, are needed.

Entities:  

Mesh:

Year:  1992        PMID: 1413834     DOI: 10.1007/bf02067349

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  20 in total

Review 1.  CLINICAL AND PATHOPHYSIOLOGIC ASPECTS OF ADRENOCORTICAL CARCINOMA.

Authors:  M B LIPSETT; R HERTZ; G T ROSS
Journal:  Am J Med       Date:  1963-09       Impact factor: 4.965

2.  Adrenocortical tumors: clinical and diagnostic findings.

Authors:  J Müller
Journal:  Recent Results Cancer Res       Date:  1990

Review 3.  Adrenocortical carcinoma.

Authors:  M F Brennan
Journal:  CA Cancer J Clin       Date:  1987 Nov-Dec       Impact factor: 508.702

4.  Differentiation between small benign and malignant adrenal masses with dynamic incremented CT.

Authors:  L L Berland; D B Koslin; P J Kenney; R J Stanley; J Y Lee
Journal:  AJR Am J Roentgenol       Date:  1988-07       Impact factor: 3.959

5.  Adrenal cortical carcinoma with invasion into the inferior vena cava.

Authors:  K Brabrand; J A Søreide
Journal:  Br J Surg       Date:  1987-07       Impact factor: 6.939

Review 6.  Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas.

Authors:  N W Thompson; P S Cheung
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

Review 7.  Complete response of metastasized adrenal cortical carcinoma with o,p'-DDD. Case report and literature review.

Authors:  E Boven; J B Vermorken; H van Slooten; H M Pinedo
Journal:  Cancer       Date:  1984-01-01       Impact factor: 6.860

8.  Magnetic resonance imaging of adrenal cortical carcinoma.

Authors:  S M Smith; S K Patel; D A Turner; T A Matalon
Journal:  Urol Radiol       Date:  1989

9.  Primary adrenocortical carcinoma: sonographic evaluation with clinical and pathologic correlation in 26 patients.

Authors:  U M Hamper; E K Fishman; D S Hartman; J L Roberts; R C Sanders
Journal:  AJR Am J Roentgenol       Date:  1987-05       Impact factor: 3.959

10.  Adrenal cortical carcinoma--a continuing challenge.

Authors:  D J Henley; J A van Heerden; C S Grant; J A Carney; P C Carpenter
Journal:  Surgery       Date:  1983-12       Impact factor: 3.982

View more
  16 in total

Review 1.  Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?

Authors:  E Baudin; S Leboulleux; A Al Ghuzlan; C Chougnet; J Young; D Deandreis; F Dumont; F Dechamps; C Caramella; P Chanson; E Lanoy; I Borget; M Schlumberger
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

2.  Andrenocortical carcinomas: twelve-year prospective experience.

Authors:  Libuse Tauchmanovà; Annamaria Colao; Luigi Antonio Marzano; Lucianna Sparano; Luigi Camera; Annalisa Rossi; Giovanna Palmieri; Ettore Marzano; Marco Salvatore; Guido Pettinato; Gaetano Lombardi; Riccardo Rossi
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

3.  Operative management for recurrent and metastatic adrenocortical carcinoma.

Authors:  Nicole M Datrice; Russell C Langan; R Taylor Ripley; Clinton D Kemp; Seth M Steinberg; Bradford J Wood; Steven K Libutti; Tito Fojo; David S Schrump; Itzhak Avital
Journal:  J Surg Oncol       Date:  2011-12-20       Impact factor: 3.454

4.  [Current TNM classification systems for adrenocortical carcinoma].

Authors:  M Fassnacht; C Wittekind; B Allolio
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

5.  The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.

Authors:  Ciara O'Sullivan; Maureen Edgerly; Margarita Velarde; Julia Wilkerson; Aradhana M Venkatesan; Stefania Pittaluga; Sherry X Yang; Dat Nguyen; Sanjeeve Balasubramaniam; Tito Fojo
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

6.  Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.

Authors:  Montserrat Ayala-Ramirez; Sina Jasim; Lei Feng; Shamim Ejaz; Ferhat Deniz; Naifa Busaidy; Steven G Waguespack; Aung Naing; Kanishka Sircar; Christopher G Wood; Lance Pagliaro; Camilo Jimenez; Rena Vassilopoulou-Sellin; Mouhammed Amir Habra
Journal:  Eur J Endocrinol       Date:  2013-10-23       Impact factor: 6.664

Review 7.  Adrenal sarcomatoid carcinoma: a case report and review of the literature.

Authors:  David Mark; Clinton Boyd; Fiona Eatock
Journal:  Ulster Med J       Date:  2014-05

8.  Case studies in hypertension. Adrenal carcinoma.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Sep-Oct       Impact factor: 3.738

9.  The insulin and igf-I pathway in endocrine glands carcinogenesis.

Authors:  Roberta Malaguarnera; Alaide Morcavallo; Antonino Belfiore
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

10.  Anatomical and functional imaging in endocrine hypertension.

Authors:  Vikas Chaudhary; Shahina Bano
Journal:  Indian J Endocrinol Metab       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.